Contrast-Induced Nephropathy: A Fact or Fiction in Lower Limb Revascularization?
Ann Vasc Surg . 2017 Oct;44:277-281. doi: 10.1016/j.avsg.2017.03.193. Epub 2017 May 4.
Fecha de la publicación: 04/05/2017
Autor: Carlos Martínez-Rico (1), Xavier Martí-Mestre (2), Antonio Romera-Villegas (2), Emma Espinar-Garcia (2), Elena Iborra-Ortega (2), Ramón Vila-Coll (2)
PMID
- PMID: 28479456
- DOI: 10.1016/j.avsg.2017.03.193
Affiliations
1Department of Endovascular and Vascular Surgery, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain; IDIBELL, Institut Investigació Biomèdica de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain. Electronic address: carlosmartinezrico@gmail.com.
2Department of Endovascular and Vascular Surgery, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain; IDIBELL, Institut Investigació Biomèdica de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
Abstract
Introduction: Contrast-induced nephropathy (CIN) is defined as an increase >25% of serum creatinine from baseline, occurring in 24-48 hours after exposure to contrast, while alternative explanations for renal impairment have been excluded. The volume administered directly relates to risk, increasing by 12% per 100 mL of contrast. According to the series, its incidence varies between 3.3% and 8% in patients without renal damage and 12-50% in patients with chronic kidney disease (CKD) and/or diabetes mellitus (DM). The purpose of this study is to determine the incidence of CIN in endovascular revascularization of lower limbs in our center, where we apply the ALARA concept (As Low As Reasonably Achievable) to the use of contrast.
Material and methods: 163 patients who underwent endovascular revascularization procedures in lower limbs were included in this prospective observational study between February 2013 and April 2015. They were classified according to clinical stage and presence of DM and/or CKD. Data included serum creatinine values preoperative and postoperative, type and volume of contrast used. Patients on hemodialysis and those without sufficient analytical data were excluded. Chi-squared test and Student t-test were used for data analysis. P < 0.05 was considered statistically significant.
Results: 109 patients were enrolled, with 67% of DM and 31.5% of CKD. CIN incidence was 3.7% in patients without DM neither CKD, in DM was 6.8% and 12.5% in CKD. Mean creatinine presurgery was 97.96 and postsurgery 97.07, finding no significant differences between them (P = 0.753). Medium-contrast volume was 37.43 mL ± 22.3. The worsening variable (creatinine postsurgery minus creatinine presurgery) was evaluated according to clinical stage, DM, or CKD, being not significant in either group.
Conclusions: In our experience, the dose administered of contrast was not related to the existence of postprocedure CIN, due to the policy of optimizing the use of contrast.
Copyright © 2017 Elsevier Inc. All rights reserved.